vs

Side-by-side financial comparison of Navitas Semiconductor Corp (NVTS) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $7.3M, roughly 1.8× Navitas Semiconductor Corp). TriSalus Life Sciences, Inc. runs the higher net margin — -73.9% vs -436.1%, a 362.2% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -59.4%). TriSalus Life Sciences, Inc. produced more free cash flow last quarter ($-2.5M vs $-8.2M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -43.9%).

Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

NVTS vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.8× larger
TLSI
$13.2M
$7.3M
NVTS
Growing faster (revenue YoY)
TLSI
TLSI
+119.3% gap
TLSI
59.8%
-59.4%
NVTS
Higher net margin
TLSI
TLSI
362.2% more per $
TLSI
-73.9%
-436.1%
NVTS
More free cash flow
TLSI
TLSI
$5.6M more FCF
TLSI
$-2.5M
$-8.2M
NVTS
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-43.9%
NVTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NVTS
NVTS
TLSI
TLSI
Revenue
$7.3M
$13.2M
Net Profit
$-31.8M
$-9.8M
Gross Margin
38.1%
86.7%
Operating Margin
-567.3%
-24.8%
Net Margin
-436.1%
-73.9%
Revenue YoY
-59.4%
59.8%
Net Profit YoY
20.2%
3.5%
EPS (diluted)
$-0.14
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVTS
NVTS
TLSI
TLSI
Q4 25
$7.3M
$13.2M
Q3 25
$10.1M
$11.6M
Q2 25
$14.5M
$11.2M
Q1 25
$14.0M
$9.2M
Q4 24
$18.0M
$8.3M
Q3 24
$21.7M
$7.3M
Q2 24
$20.5M
$7.4M
Q1 24
$23.2M
$6.5M
Net Profit
NVTS
NVTS
TLSI
TLSI
Q4 25
$-31.8M
$-9.8M
Q3 25
$-19.2M
$-10.8M
Q2 25
$-49.1M
$-8.3M
Q1 25
$-16.8M
$-10.4M
Q4 24
$-39.9M
$-10.1M
Q3 24
$-18.7M
$-2.4M
Q2 24
$-22.3M
$-4.3M
Q1 24
$-3.7M
$-13.2M
Gross Margin
NVTS
NVTS
TLSI
TLSI
Q4 25
38.1%
86.7%
Q3 25
37.9%
83.5%
Q2 25
16.1%
83.9%
Q1 25
37.9%
83.7%
Q4 24
12.4%
85.3%
Q3 24
39.7%
86.3%
Q2 24
39.0%
87.6%
Q1 24
41.1%
85.0%
Operating Margin
NVTS
NVTS
TLSI
TLSI
Q4 25
-567.3%
-24.8%
Q3 25
-192.0%
-77.9%
Q2 25
-149.4%
-65.4%
Q1 25
-180.5%
-79.9%
Q4 24
-216.9%
-91.8%
Q3 24
-133.6%
-118.9%
Q2 24
-152.1%
-111.0%
Q1 24
-136.2%
-180.8%
Net Margin
NVTS
NVTS
TLSI
TLSI
Q4 25
-436.1%
-73.9%
Q3 25
-190.2%
-93.5%
Q2 25
-338.7%
-73.9%
Q1 25
-120.1%
-113.2%
Q4 24
-221.7%
-122.4%
Q3 24
-86.4%
-32.6%
Q2 24
-109.1%
-58.8%
Q1 24
-15.9%
-204.5%
EPS (diluted)
NVTS
NVTS
TLSI
TLSI
Q4 25
$-0.14
$-0.22
Q3 25
$-0.09
$-0.96
Q2 25
$-0.25
$-0.27
Q1 25
$-0.09
$-0.39
Q4 24
$-0.22
$-0.38
Q3 24
$-0.10
$-0.12
Q2 24
$-0.12
$-0.21
Q1 24
$-0.02
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVTS
NVTS
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$236.9M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$443.7M
$-33.9M
Total Assets
$500.5M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVTS
NVTS
TLSI
TLSI
Q4 25
$236.9M
$20.4M
Q3 25
$150.6M
$22.7M
Q2 25
$161.2M
$26.5M
Q1 25
$75.1M
$13.0M
Q4 24
$86.7M
$8.5M
Q3 24
$98.3M
$11.3M
Q2 24
$111.7M
$16.5M
Q1 24
$128.9M
$4.0M
Stockholders' Equity
NVTS
NVTS
TLSI
TLSI
Q4 25
$443.7M
$-33.9M
Q3 25
$371.0M
$-26.7M
Q2 25
$388.9M
$-19.4M
Q1 25
$341.8M
$-34.4M
Q4 24
$348.0M
$-25.9M
Q3 24
$380.8M
$-20.4M
Q2 24
$388.1M
$-25.3M
Q1 24
$397.9M
$-36.0M
Total Assets
NVTS
NVTS
TLSI
TLSI
Q4 25
$500.5M
$35.3M
Q3 25
$430.2M
$36.5M
Q2 25
$449.4M
$41.3M
Q1 25
$370.8M
$28.6M
Q4 24
$390.0M
$24.0M
Q3 24
$419.4M
$27.5M
Q2 24
$439.1M
$32.4M
Q1 24
$467.9M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVTS
NVTS
TLSI
TLSI
Operating Cash FlowLast quarter
$-8.1M
$-2.5M
Free Cash FlowOCF − Capex
$-8.2M
$-2.5M
FCF MarginFCF / Revenue
-111.8%
-19.1%
Capex IntensityCapex / Revenue
0.7%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-44.4M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVTS
NVTS
TLSI
TLSI
Q4 25
$-8.1M
$-2.5M
Q3 25
$-10.0M
$-3.7M
Q2 25
$-11.2M
$-7.3M
Q1 25
$-13.5M
$-4.5M
Q4 24
$-10.2M
$-5.7M
Q3 24
$-13.7M
$-10.8M
Q2 24
$-15.1M
$-13.4M
Q1 24
$-19.8M
$-10.9M
Free Cash Flow
NVTS
NVTS
TLSI
TLSI
Q4 25
$-8.2M
$-2.5M
Q3 25
$-10.7M
$-3.9M
Q2 25
$-11.9M
$-7.4M
Q1 25
$-13.6M
$-5.3M
Q4 24
$-10.8M
$-5.8M
Q3 24
$-14.3M
$-11.0M
Q2 24
$-17.9M
$-13.5M
Q1 24
$-22.7M
$-10.9M
FCF Margin
NVTS
NVTS
TLSI
TLSI
Q4 25
-111.8%
-19.1%
Q3 25
-106.1%
-33.9%
Q2 25
-82.2%
-66.1%
Q1 25
-96.8%
-57.3%
Q4 24
-59.8%
-69.7%
Q3 24
-65.9%
-149.9%
Q2 24
-87.3%
-183.1%
Q1 24
-97.9%
-169.3%
Capex Intensity
NVTS
NVTS
TLSI
TLSI
Q4 25
0.7%
0.3%
Q3 25
7.0%
1.9%
Q2 25
4.7%
0.8%
Q1 25
0.3%
8.2%
Q4 24
3.1%
0.6%
Q3 24
2.6%
2.3%
Q2 24
13.4%
0.8%
Q1 24
12.5%
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons